Calidi Biotherapeutics (CLDI) Cash & Equivalents (2022 - 2025)
Calidi Biotherapeutics' quarterly Cash & Equivalents came in at $219000.0 in Q4 2025, down 97.72% year-on-year from $9.6 million in Q4 2024, and down 97.89% quarter-over-quarter from $10.4 million in Q3 2025.
Calidi Biotherapeutics has reported Cash & Equivalents for 4 years, with the latest figure at $219000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents fell 97.72% year-over-year to $219000.0; the trailing twelve-month figure through Dec 2025 stood at $219000.0 (down 97.72% YoY), and the FY2025 full-year result was $219000.0, down 97.72% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $219000.0, down from $10.4 million in the prior quarter.
- The five-year high for Cash & Equivalents was $10.6 million in Q1 2025, with the low at $218000.0 in Q4 2022.
- Average Cash & Equivalents over 4 years is $3.7 million, with a median of $1.1 million recorded in 2024.
- Year-over-year, Cash & Equivalents surged 2040.85% in 2024 and tumbled 97.72% in 2025.
- Tracing CLDI's Cash & Equivalents over 4 years: stood at $218000.0 in 2022, then jumped by 105.5% to $448000.0 in 2023, then surged by 2040.85% to $9.6 million in 2024, then plunged by 97.72% to $219000.0 in 2025.
- The last three Cash & Equivalents figures came in at $219000.0 (Q4 2025), $10.4 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Calidi Biotherapeutics | - | - | - | 219,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 219,000.00 |
| Sep 30, 2025 | 10.40 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 10.60 Mn |
| Dec 31, 2024 | 9.59 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 836,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 448,000.00 |
| Sep 30, 2023 | 218,000.00 |
| Dec 31, 2022 | 218,000.00 |